CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
CervoMed Inc. (CRVO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-07
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $358.34K 10-K · filed 2025-03-17 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 10-K · filed 2023-03-24 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | |
| 2021-09-30 | $33.79K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $219.23K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $23.16K 10-Q · filed 2022-05-12 | $475.26K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $289.07K 10-K · filed 2022-03-18 | |
| 2019-03-31 | $96.72K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $143.00 10-K · filed 2020-03-17 | |
| 2017-12-31 | $4.75K 10-K · filed 2019-03-19 | $4.73K 10-K · filed 2018-04-02 |
| 2016-12-31 | $94.60K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |